Acadian Asset Management LLC Astrazeneca PLC Transaction History
Acadian Asset Management LLC
- $48.4 Billion
- Q2 2025
A detailed history of Acadian Asset Management LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Acadian Asset Management LLC holds 2,043,850 shares of AZN stock, worth $154 Million. This represents 0.29% of its overall portfolio holdings.
Number of Shares
2,043,850
Previous 82,086
2389.89%
Holding current value
$154 Million
Previous $6.03 Million
2268.13%
% of portfolio
0.29%
Previous 0.02%
Shares
25 transactions
Others Institutions Holding AZN
# of Institutions
1,418Shares Held
501MCall Options Held
7.79MPut Options Held
2.48M-
Price T Rowe Associates Inc Baltimore, MD51.9MShares$3.91 Billion0.41% of portfolio
-
Primecap Management CO Pasadena, CA41.2MShares$3.1 Billion2.35% of portfolio
-
Wellington Management Group LLP Boston, MA34.3MShares$2.59 Billion0.45% of portfolio
-
Capital International Investors Los Angeles, CA31.4MShares$2.37 Billion0.39% of portfolio
-
Bank Of America Corp Charlotte, NC31.2MShares$2.35 Billion0.16% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $233B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...